journal article·2024-08Open access

Necroptosis‐Mediated Synergistic Photodynamic and Glutamine‐Metabolic Therapy Enabled by a Biomimetic Targeting Nanosystem for Cholangiocarcinoma

Qichang Zheng, Tianhao Zou, Weimin Wang, Chen Zhang, Shaobo Hu, Xiang Cheng, Ran Liu, Guoliang Wang, Ping Sun, Xing Zhou, Bing Yang, Jianjun Xu, Yang Gao, Jinyang Gu

Advanced Science· Volume 11· Issue 29

Abstract

Abstract Targeted delivery of glutamine metabolism inhibitors holds promise for cholangiocarcinoma therapy, yet effective delivery vehicles remain a challenge. This study reports the development of a biomimetic nanosystem, termed R‐CM@MSN@BC, integrating mesoporous organosilicon nanoparticles with reactive oxygen species‐responsive diselenide bonds for controlled release of the glutamine metabolism inhibitor bis‐2‐(5‐phenylacetamido‐1,3,4‐thiadiazol‐2‐yl) ethyl sulfide (BPTES) and the photosensitizer Ce6. Erythrocyte membrane coating, engineered with Arg‐Gly‐Asp (RGD) peptides, not only enhanced biocompatibility but also improved tumor targeting and tissue penetration. Upon laser irradiation, R‐CM@MSN@BC executed both photodynamic and glutamine‐metabolic therapies, inducing necroptosis in tumor cells and triggering significant immunogenic cell death. Time‐of‐flight mass cytometry analysis revealed that R‐CM@MSN@BC can remodel the immunosuppressive tumor microenvironment by polarizing M1‐type macrophages, reducing infiltration of M2‐type and CX3CR1+ macrophages, and decreasing T cell exhaustion, thereby increasing the effectiveness of anti‐programmed cell death ligand 1 immunotherapy. This strategy proposed in this study presents a viable and promising approach for the treatment of cholangiocarcinoma.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer Research and Treatments · Cancer Immunotherapy and Biomarkers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center for Liver Transplantation Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430022 China

Cancer Center Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430022 China

Department of Hepatobiliary Surgery Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430022 China

Key Laboratory of Organ Transplantation Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation Chinese Academy of Medical Sciences Wuhan Hubei 430022 China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Hubei Province · Fundamental Research Funds for the Central Universities

References (42)

Show source-provided references
1. 10.1038/s41572-021-00300-210.1038/s41572-021-00300-2 ↗
2. 10.1016/j.ccell.2019.04.00710.1016/j.ccell.2019.04.007 ↗
3. 10.1038/s41575-020-0310-z10.1038/s41575-020-0310-z ↗
4. 10.1126/science.aar406010.1126/science.aar4060 ↗
5. 10.1038/s41575-022-00741-410.1038/s41575-022-00741-4 ↗
6. 10.3322/caac.2175910.3322/caac.21759 ↗
7. 10.1001/jamaoncol.2020.093010.1001/jamaoncol.2020.0930 ↗
8. 10.1016/j.jhep.2022.11.00510.1016/j.jhep.2022.11.005 ↗
9. 10.1016/j.immuni.2019.12.01110.1016/j.immuni.2019.12.011 ↗
10. 10.1016/j.ccell.2023.02.01610.1016/j.ccell.2023.02.016 ↗
11. 10.1016/j.cmet.2022.04.00310.1016/j.cmet.2022.04.003 ↗
12. 10.1200/JCO.2005.19.72910.1200/JCO.2005.19.729 ↗
13. 10.1021/acs.chemrev.8b0062610.1021/acs.chemrev.8b00626 ↗
14. 10.1038/nrc.2016.7110.1038/nrc.2016.71 ↗
15. 10.1038/s41590-022-01398-610.1038/s41590-022-01398-6 ↗
16. 10.1016/j.cmet.2022.11.01310.1016/j.cmet.2022.11.013 ↗
17. 10.1016/j.jhep.2022.04.03810.1016/j.jhep.2022.04.038 ↗
18. 10.1038/s41586-021-03442-110.1038/s41586-021-03442-1 ↗
19. 10.1016/j.jhep.2019.12.01510.1016/j.jhep.2019.12.015 ↗
20. 10.1002/advs.20210588510.1002/advs.202105885 ↗
21. 10.1126/science.aaw547310.1126/science.aaw5473 ↗
22. 10.1016/j.cell.2018.10.00110.1016/j.cell.2018.10.001 ↗
23. 10.1016/j.molcel.2020.10.01510.1016/j.molcel.2020.10.015 ↗
24. 10.1038/nrclinonc.2016.6010.1038/nrclinonc.2016.60 ↗
25. 10.1007/BF0021693610.1007/BF00216936 ↗
26. 10.1002/advs.20220270210.1002/advs.202202702 ↗
27. 10.1016/j.immuni.2014.09.01610.1016/j.immuni.2014.09.016 ↗
28. 10.1002/adma.20230023210.1002/adma.202300232 ↗
29. 10.1080/2162402X.2016.114967310.1080/2162402X.2016.1149673 ↗
30. 10.1038/s41392-022-00966-410.1038/s41392-022-00966-4 ↗
31. 10.1002/adma.20200438510.1002/adma.202004385 ↗
32. 10.1093/nar/gkx24710.1093/nar/gkx247 ↗
33. 10.1016/j.ebiom.2018.11.06310.1016/j.ebiom.2018.11.063 ↗
34. 10.1038/s41467-023-38371-210.1038/s41467-023-38371-2 ↗
35. 10.1016/j.immuni.2018.07.00810.1016/j.immuni.2018.07.008 ↗
36. 10.1038/s41587-019-0201-410.1038/s41587-019-0201-4 ↗
37. 10.1093/bioinformatics/btac16610.1093/bioinformatics/btac166 ↗
38. 10.1093/bioinformatics/btp61610.1093/bioinformatics/btp616 ↗
39. 10.1093/nar/gkv00710.1093/nar/gkv007 ↗
40. 10.1186/s40659-019-0243-610.1186/s40659-019-0243-6 ↗
41. 10.1016/j.freeradbiomed.2017.04.01010.1016/j.freeradbiomed.2017.04.010 ↗
42. 10.1001/jamaoncol.2020.093010.1001/jamaoncol.2020.0930 ↗